$-0.02
(Market cap
$71 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
1.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-2.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.2
-
Face value
--
-
Shares outstanding
49,221,246
10 Years Aggregate
CFO
$-78.60 Mln
EBITDA
$-120.10 Mln
Net Profit
$-114.31 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medicinova (MNOV)
| 22.1 | 20.2 | 21.1 | 21.1 | -12.4 | -17.4 | -12.4 |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Medicinova (MNOV)
| -37.6 | 39.6 | -26.8 | -23.5 | -49.0 | -22.0 | -17.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medicinova (MNOV)
|
1.6 | 70.6 | 0.9 | -10.8 | -916.1 | -27.3 | -- | 1.9 |
| 84.8 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 268.4 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 72.4 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 59.0 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 110.2 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 355.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 118.2 | 9,718.7 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.6 | |
| 541.4 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 592.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 |
Shareholding Pattern
View DetailsAbout Medicinova (MNOV)
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory... and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California. Read more
-
Co-Founder, President, CEO & Executive Director
Dr. Yuichi Iwaki M.D., Ph.D.
-
Co-Founder, President, CEO & Executive Director
Dr. Yuichi Iwaki M.D., Ph.D.
-
Headquarters
La Jolla, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Medicinova (MNOV)
What is the current share price of Medicinova Inc (MNOV) Today?
The share price of Medicinova Inc (MNOV) is $1.60 (NASDAQ) as of 04-Sep-2026 13:20 EDT. Medicinova Inc (MNOV) has given a return of -12.42% in the last 3 years.
What is the current PB & PE ratio of Medicinova Inc (MNOV)?
Since, TTM earnings of Medicinova Inc (MNOV) is negative, P/E ratio is not available.
The P/B ratio of Medicinova Inc (MNOV) is 1.88 times as on 28-Aug-2026, a 64 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-5.36 |
1.55 |
2024 |
-9.32 |
1.96 |
2023 |
-8.58 |
1.18 |
2022 |
-7.15 |
1.43 |
2021 |
-12.95 |
1.57 |
What is the 52 Week High and Low of Medicinova Inc (MNOV)?
The 52-week high and low of Medicinova Inc (MNOV) are Rs 1.96 and Rs 1.17 as of 06-Sep-2026.
What is the market cap of Medicinova Inc (MNOV)?
Medicinova Inc (MNOV) has a market capitalisation of $ 71 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Medicinova Inc (MNOV)?
Before investing in Medicinova Inc (MNOV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.